Key Highlights
- Aehr Test Systems shares climbed 15.41% Thursday following announcement of a historic $41 million production contract from a hyperscale client.
- The contract covers package-level burn-in services for custom AI processor ASICs utilizing Aehr’s Sonoma high-power platform.
- Shipments commence in fiscal year 2027, beginning June 27, 2026.
- A board director divested $1.21 million worth of shares on April 16, one day prior to the public announcement.
- Analyst community maintains a Strong Buy rating with an average target price of $62.
Aehr Test Systems secured its largest contract ever Thursday, capturing Wall Street’s attention. The semiconductor testing firm revealed a $41 million production agreement with its primary hyperscale client for package-level burn-in services involving custom AI processor ASICs. AEHR shares rallied 15.41% following the disclosure.
The agreement encompasses a substantial quantity of Aehr’s Sonoma high-power package-level test and burn-in platforms. The contract additionally includes turnkey burn-in modules along with device-specific sockets designed to configure the systems for particular AI processors.
This represents a follow-on contract, indicating the hyperscale client — whose name remains undisclosed — maintains an established relationship with Aehr. The agreement strengthens an already expanding partnership.
Shipments are scheduled to commence during Aehr’s fiscal year 2027, launching on June 27, 2026. This timeline provides the company with predictable near-term revenue visibility.
CEO Gayn Erickson emphasized this milestone represents the beginning of expanded opportunities. He highlighted that the customer is simultaneously developing a next-generation, higher-power AI accelerator ASIC anticipated to enter production later this year.
Aehr has already secured an initial order from this same client for multiple Sonoma systems to facilitate production of the advanced device. This $41 million agreement appears to signal the opening phase of a broader expansion.
“As these next-generation devices move into volume production, we see the potential for further substantial increases in demand for Sonoma systems and consumables in our next fiscal year,” Erickson stated.
Impressive Performance Leading to Major Announcement
Thursday’s rally continues an extraordinary trajectory for AEHR. The stock has advanced 246.95% year-to-date and surged 805.07% over the trailing 12 months.
Trading volume reached over 1.75 million AEHR shares during the session, approaching the three-month average daily volume of approximately 2.77 million.
The historic order follows robust Q3 2026 performance. Revenue reached $10.3 million, marginally below the $10.8 million projection, while the company achieved record quarterly bookings of $37.2 million. This performance elevated its backlog beyond $50 million.
Regarding earnings per share, Aehr exceeded projections — delivering -$0.05 compared to the anticipated -$0.07.
Wall Street and Internal Trading Activity
Analyst community has been elevating price objectives. Freedom Broker increased its target to $61 from $38 while keeping a Hold designation. Lake Street elevated its target to $56 from $50, referencing robust booking momentum, and maintained its Buy recommendation.
The collective Wall Street assessment stands at Strong Buy, featuring three Buy recommendations over the past three months. The average target price reaches $62, suggesting approximately 26.67% potential appreciation from present levels.
Regarding internal transactions, Director Rhea J. Posedel divested 15,000 shares on April 16 at $80.72 per share, amounting to $1.21 million. After this transaction, Posedel maintains direct ownership of 71,163 shares, along with an additional 411,979 shares held indirectly via a trust.
